Drugs In The Making
  • Shruti's Blog
  • About Shruti Bhat
  • QUALITY BLOG
  • Industry News
  • Free Ebook
  • Research Updates
    • Drug Research
    • Clinical Research
  • Contact

Drug Research Updates

Drug Research and Technology highlights

11/10/2009

0 Comments

 
Here are some updates on drug research and technology from my reading- 

Nicotine vaccines- do experiments show failure to meet primary endpoint?

The Times "Booster Shots" blog reported that a company working on an "anti-smoking vaccine" similar to the much anticipated product undergoing testing by Nabi Pharmaceuticals "has not been so successful."

Studies see increased skin cancer risk in patients taking anti-TNF drugs.


Medical conference reports at the the American College of Rheumatology, stated that, "Rheumatoid arthritis patients treated with potent tumor necrosis factor inhibitors ran an increased risk of developing skin cancer."

FDA strengthens warning for Dexferrum.


USFDA website reported that, "The FDA has strengthened the black box warning for injectable iron dextran (Dexferrum), cautioning physicians to try a test dose first, due to a risk of anaphalactic reactions and even death." The altered warning "cautions that fatal reactions have occurred even after the test dose was tolerated."  

Three-day antibiotic course may be sufficient for pediatric tonsillectomy patients -

According to a scientific publication reported in the Archives of Otolaryngology-Head & Neck Surgery, three days of antibiotics after a tonsillectomy will put kids back on a normal diet and activity level. Several studies have demonstrated that postoperative antibiotics reduce pain, thought to be caused when normal oral bacteria colonize the tonsillar fossae and cause inflammation. 

For indepth reading on this topic, please visit- http://www.pharm-education.com/2009/11/drug-research-and-technology-highlights.html 

Disclaimer : The above information has been cited from literature in public domain. This is for research purpose/ dissemination of knowledge only and should not be construed as medical advise. 
0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    shruti bhat, pharmaceutical manufacturing and continuous improvement expert
    Dr. Shruti Bhat

    Pharmaceutical Manufacturing, Continuous Improvement and Business Transformation Consultant


    Picture

    how to choose business process improvement methodology
    18 business process improvement methodologies, shruti bhat

    Categories

    All
    Drug Research Updates


      Contact

    SEND
Disclaimer:

The website, blog information, audios, videos, white papers and all other associated published content on this website is the sole property of Innoworks, Canada and is under Copy Right protection. Not to be copied, distributed or used without prior authorization of the owner. The blog provides information for general knowledge sharing for community benefit and is for academic purpose only. Please give courtesy credits to respective authors in case information published here is used as a reference.
 
Additionally, information published on the blog, resource library etc. should not be considered or construed as legal and/or medical advice.  For diagnosis of an ailment, it is recommended that one seeks help of a registered medical practitioner, while medicines should be received from a registered pharmacist only. Seek advise of registered legal expert for any information pertaining law(s).

 The authors and website owner have used their best efforts in preparing this site. The information contained herein has been stated accurately to the best ability of the authors. The information contained herein is strictly for educational purposes. The author and website owner make no representation or warranties with respect to the accuracy, contrary interpretations of the subject matter herein, applicability, fitness or completeness of the contents. Therefore, if you wish to apply ideas contained on this website, you are taking full responsibility for your actions. The author and website owner specifically disclaim any liability that is incurred from the use or application of the contents sated here.

Please note that by continuing to read this site, you agree that you have read and understood this disclaimer and are continuing to read or utilize information from this site at your own responsibility and risk. Under no circumstances can you hold us responsible for any outcome or result from your having read or followed any of the expressions/suggestions/recommendations from this site.  We hope you expand your understanding and that many of the ideas and suggestions provided on this site help you. BUT we do not take on any implicit or explicit liability for anyone following any of those suggestions, ideas or advices. This is also applicable for any comments and discussions being carried out on this site.
 
For queries regarding any posted content, please feel free to contact the web administrator using contact form.
Terms & Conditions of site usage

©
2001- 2017 Copyrighted content, ALL RIGHTS RESERVED.


  • Shruti's Blog
  • About Shruti Bhat
  • QUALITY BLOG
  • Industry News
  • Free Ebook
  • Research Updates
    • Drug Research
    • Clinical Research
  • Contact